Special Import - Pirfenex 200 Mg 30 Tablets

Pirfenex 200 Mg 30 Tablets

Description:

Pirfenex 200 mg is a prescription oral antifibrotic medicine containing pirfenidone, specifically indicated for the treatment of idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive lung disease characterized by scarring (fibrosis) of lung tissue, leading to worsening shortness of breath and reduced lung function. Pirfenex helps slow the progression of fibrosis through its anti-inflammatory, antioxidant, and antifibrotic actions, supporting better preservation of lung capacity and reducing the risk of acute exacerbations in adults diagnosed with IPF. This product is intended for use under the supervision of a specialist physician experienced in managing interstitial lung diseases.

Indications:

• Treatment of idiopathic pulmonary fibrosis (IPF) in adults.
• Helps slow the decline in lung function associated with IPF.
• May reduce the frequency and severity of acute exacerbations of IPF.
• Supports symptom management related to IPF such as progressive shortness of breath, dry cough, and reduced exercise tolerance (as part of a comprehensive treatment plan).

Active Ingredients / Key Components:

• Pirfenidone – 200 mg per tablet.
• Excipients: The full list of inactive ingredients (excipients, coloring agents, preservatives, etc.) is not available in the provided information. Please refer to the official package insert for complete composition.

Dosage & Administration / How to Use:

• Pirfenex 200 mg tablets are for oral use only and should be taken exactly as prescribed by your treating physician.
• Tablets are usually taken with food to help reduce gastrointestinal side effects such as nausea and stomach discomfort.
• Standard treatment with pirfenidone is typically initiated with a gradual dose-escalation schedule (titration) over the first weeks of therapy, then continued at a maintenance dose. The exact dosing regimen (number of tablets per dose and frequency per day) must be determined by the physician based on clinical guidelines, patient tolerance, and response.
• Swallow the tablets whole with a glass of water. Do not crush, break, or chew the tablets unless specifically instructed by your healthcare provider.
• If a dose is missed, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed dose.
• Do not stop taking Pirfenex or change the dose without consulting your doctor, even if you feel better, as IPF is a chronic condition requiring long-term management.
• Avoid excessive exposure to sunlight and UV light during treatment and use appropriate sun protection, as pirfenidone may increase photosensitivity.

Clinical Benefits:

• Slows progression of idiopathic pulmonary fibrosis by reducing lung tissue scarring and fibrosis.
• Exerts anti-inflammatory and antioxidant effects that help limit ongoing lung damage in IPF.
• Helps preserve lung function over time, supporting better breathing capacity and daily activity levels.
• May reduce the risk and frequency of acute exacerbations (sudden worsening) of IPF, which are associated with poorer outcomes.
• Forms part of a comprehensive, guideline-directed treatment approach for adults with IPF under specialist supervision.

Warnings & Contraindications:

• Use only under medical supervision. Pirfenex is a prescription medicine for idiopathic pulmonary fibrosis and should not be used for any other lung condition unless specifically prescribed.
• Contraindicated in patients with known hypersensitivity or allergy to pirfenidone or any of the excipients in the formulation.
• Use with caution in patients with liver impairment. Baseline and periodic liver function tests (ALT, AST, bilirubin) are recommended. Treatment may need to be adjusted, interrupted, or discontinued if significant liver enzyme elevations occur.
• Use with caution in patients with kidney impairment. Dose adjustment or close monitoring may be required in moderate renal impairment; severe renal impairment or end-stage renal disease may require avoidance of therapy as per physician judgment.
• Avoid or limit alcohol consumption during treatment, as alcohol can increase the risk of liver toxicity.
• Photosensitivity risk: Pirfenidone may cause increased sensitivity to sunlight. Avoid direct sun exposure and tanning beds, and use broad-spectrum sunscreen, protective clothing, hats, and sunglasses when outdoors.
• Drug interactions: Inform your doctor about all medications you are taking, including prescription drugs, over-the-counter products, and herbal supplements. Certain medicines (e.g., strong CYP1A2 inhibitors or inducers) may affect pirfenidone levels and require dose adjustment or avoidance.
• Consult your doctor before use if pregnant, nursing, planning pregnancy, or if you are a woman of childbearing potential. The safety of pirfenidone in pregnancy and breastfeeding is not well established; your doctor will weigh potential benefits and risks.
• Use with caution in patients with a history of serious skin reactions, severe photosensitivity, or significant gastrointestinal disorders.
• May cause dizziness or fatigue in some patients. If affected, do not drive, operate machinery, or perform tasks requiring alertness until you know how the medicine affects you.
• Not intended to diagnose, treat, cure, or prevent any disease other than those specifically approved in the product labeling (idiopathic pulmonary fibrosis). Always follow your physician’s instructions.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, loss of appetite, indigestion, stomach pain, diarrhea, fatigue, dizziness, headache, and weight loss.
• Skin-related side effects such as rash, redness, itching, or photosensitivity reactions (sunburn-like reactions) may occur, especially with sun exposure.
• Elevations in liver enzymes (ALT, AST) or other liver function abnormalities can occur. Your doctor may monitor your liver tests regularly during treatment.
• Less common but potentially serious side effects may include severe skin reactions, significant liver injury (e.g., jaundice, dark urine, persistent nausea, right upper abdominal pain), or severe allergic reactions (swelling of face, lips, tongue, difficulty breathing). Seek immediate medical attention if these occur.
• If you experience persistent or severe side effects, or any new or unusual symptoms, contact your doctor promptly. Do not stop or change the dose without medical advice.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the container tightly closed and store at or below the temperature specified on the package insert (usually below 30℃, unless otherwise stated). Do not use after the expiry date printed on the pack. Keep out of reach of children.

Specifications:

• Product type: Prescription antifibrotic medicine for idiopathic pulmonary fibrosis.
• Active ingredient strength: Pirfenidone 200 mg per tablet.
• Form: Oral tablet.
• Pack size: 30 tablets per pack.
• Intended users: Adults diagnosed with idiopathic pulmonary fibrosis, under specialist medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.